THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY

Volume: 1 Number: 1 January 1, 2017
  • Sevil Uygun İlikhan
  • Taner Bayraktarıoğlu
EN TR

THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY

Abstract

There is increasing evidence that cortisol produces adverse metabolic syndrome and type 2 diabetes on adipose tissue. In obesity, 11 β HSD1 upregulation has been shown to correlate with waist circumference, body mass index (BMI), and insulin resistance. 11 β HSD1 is downregulated in Cushing’s syndrome. It is indicated that it is adjusted with local cortisol levels independently of plasma levels. It is thought that 11b β HSD1 plays a complex pathophysiological role in metabolic syndrome and obesity. Clinical trials are planned for the efficacy of selective 11 β HSD1 inhibitors

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Sevil Uygun İlikhan This is me

Taner Bayraktarıoğlu This is me

Publication Date

January 1, 2017

Submission Date

January 1, 2017

Acceptance Date

-

Published in Issue

Year 2017 Volume: 1 Number: 1

APA
İlikhan, S. U., & Bayraktarıoğlu, T. (2017). THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY. Turkish Journal of Diabetes and Obesity, 1(1), 14-19. https://izlik.org/JA79SM28PE
AMA
1.İlikhan SU, Bayraktarıoğlu T. THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY. Turk J Diab Obes. 2017;1(1):14-19. https://izlik.org/JA79SM28PE
Chicago
İlikhan, Sevil Uygun, and Taner Bayraktarıoğlu. 2017. “THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY”. Turkish Journal of Diabetes and Obesity 1 (1): 14-19. https://izlik.org/JA79SM28PE.
EndNote
İlikhan SU, Bayraktarıoğlu T (January 1, 2017) THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY. Turkish Journal of Diabetes and Obesity 1 1 14–19.
IEEE
[1]S. U. İlikhan and T. Bayraktarıoğlu, “THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY”, Turk J Diab Obes, vol. 1, no. 1, pp. 14–19, Jan. 2017, [Online]. Available: https://izlik.org/JA79SM28PE
ISNAD
İlikhan, Sevil Uygun - Bayraktarıoğlu, Taner. “THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY”. Turkish Journal of Diabetes and Obesity 1/1 (January 1, 2017): 14-19. https://izlik.org/JA79SM28PE.
JAMA
1.İlikhan SU, Bayraktarıoğlu T. THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY. Turk J Diab Obes. 2017;1:14–19.
MLA
İlikhan, Sevil Uygun, and Taner Bayraktarıoğlu. “THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY”. Turkish Journal of Diabetes and Obesity, vol. 1, no. 1, Jan. 2017, pp. 14-19, https://izlik.org/JA79SM28PE.
Vancouver
1.Sevil Uygun İlikhan, Taner Bayraktarıoğlu. THE 11 Β -HYDROXYSTEROİD DEHYDROGENASE ENZYME AND OBESİTY. Turk J Diab Obes [Internet]. 2017 Jan. 1;1(1):14-9. Available from: https://izlik.org/JA79SM28PE

Turkish Journal of Diabetes and Obesity (Turk J Diab Obes) is a scientific publication of Zonguldak Bulent Ecevit University Obesity and Diabetes Research and Application Center.

A Collaboration Protocol was signed between the Turkish Obesity Research Association and Zonguldak Bülent Ecevit University by taking an important step from the Turkish Journal of Diabetes and Obesity. As the Turkish Journal of Diabetes and Obesity, we are proud to open the doors of a new era in scientific publishing. With the collaboration of the Turkish Obesity Research Association and Zonguldak Bülent Ecevit University, our journal will now serve as a joint publication platform.

This is a refereed journal, which is published in printed and electronic forms. It aims at achieving free knowledge to the related national and international organizations and individuals.

This journal is published annually three times (in April, August and December).

The publication language of the journal is Turkish and English.